OCA 5 mg ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
94	Primary sclerosing cholangitis	1

94. Primary sclerosing cholangitis

Clinical trials : 148 / Drugs : 118 - (DrugBank : 39) / Drug target genes : 18 - Drug target pathways : 141

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-002205-38-IT (EUCTR)	02/12/2015	12/02/2018	A Study of Obeticholic Acid (OCA) in Patients with Primary Sclerosing Cholangitis	A Phase 2, Randomized, Double-Blind, Placebo-Controlled,Dose-Finding, Clinical Trial Evaluating the ...	Primary Sclerosing Cholangitis MedDRA version: 20.0;Level: SOC;Classification code 10019805;Term: He ...	Product Name: OCA 1,5 mg Product Code: INT-747, OCA INN or Proposed INN: ACIDO OBETICOLICO Other descri ...	INTERCEPT PHARMACEUTICALS INC.	NULL	Not Recruiting			Female: yes Male: yes	75	Phase 2	United States;Italy

First Previous1Next Last